國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12190/12972 (94%)
造訪人次 : 1060922      線上人數 : 723
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版
    鄰近類別
    圖書 [2/4]
    會議論文/會議摘要 [16/16]

    類別統計

    近3年內發表的文件:0(0.00%)
    含全文筆數:48(97.96%)

    文件下載次數統計
    下載大於0次:48(100.00%)
    下載大於100次:48(100.00%)
    檔案下載總次數:36442(75.25%)

    最後更新時間: 2024-12-11 16:45


    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目1-49 / 49. (共1頁)
    1 
    每頁顯示[10|25|50]項目

    日期題名關聯
    2015-02 Effects of genetic variants of ADH1B and ALDH2 and social network on continued alcohol drinking among young adolescents in Taiwan Drug and Alcohol Dependence. 2015 Feb;147:38-45.
    2014-05 Assessment of CYP450 genetic variability effect on methadone dose and tolerance Pharmacogenomics. 2014 May;15(7):977-986.
    2014-04 The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance Journal of Clinical Psychopharmacology. 2014 Apr;34(2):205-211.
    2013-12 Pharmacogenomics study in a Taiwanese methadone maintenance cohort Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S62-S68.
    2013-11 Comparison of escitalopram and paroxetine in the treatment of major depressive disorder International Clinical Psychopharmacology. 2013 Nov;28(6):339-345.
    2013-09 Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort OMICS :A Journal of Integrative Biology. 2013 Sep;17(10):519-526.
    2013-07 CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions Pharmacogenomics. 2013 Jul;14(10):1191-1201.
    2013-04 Psychotropic drugs and risk of motor vehicle accidents: A population-based case-control study British Journal of Clinical Pharmacology. 2013 Apr;75(4):1125-1133.
    2013-02 OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study Journal of Human Genetics. 2013 Feb;58(2):84-90.
    2013-02 PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites Journal of Clinical Psychopharmacology. 2013 Feb;33(1):137-140.
    2012-10 Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients European Neuropsychopharmacology. 2012 Oct;22(10):695-703.
    2012-10 Overlapping prescriptions of stimulants for children and adolescents with attention-deficit hyperactivity disorder Psychiatric Services. 2012 Oct;63(10):1011-1018.
    2012-07 Gender differences in widowhood effects among community-dwelling elders by causes of death in Taiwan Annals of Epidemiology. 2012 Jul;22(7):457-465.
    2012-04 ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics [Erratum:Pharmacogenomics Journal. 2010 Feb;10(1): 30-39.] Pharmacogenomics Journal. 2012 Apr;12(2):184.
    2011-10 Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients Pharmacogenomics. 2011 Oct;12(10):1397-1406.
    2011-08 CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469.
    2011-08 Depression trajectories and obesity among the elderly in Taiwan Psychological Medicine. 2011 Aug;41(8):1665-1676.
    2011-08 Five-year trajectories of long-term benzodiazepine use by adolescents: Patient, provider, and medication factors Psychiatric Services. 2011 Aug;62(8):900-907.
    2011-06 Differential effects of predictors on methylphenidate initiation and discontinuation among young people with newly diagnosed attention-deficit/hyperactivity disorder Journal of Child and Adolescent Psychopharmacology. 2011 Jun;21(3):265-273.
    2011-04 ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170.
    2011-04 Multilevel influences of school and family on alcohol-purchasing behaviors in school-aged children Drug and Alcohol Dependence. 2011 Apr;114(2-3):127-1377.
    2011-02 Effect of benzodiazepine discontinuation on dementia risk American Journal of Geriatric Psychiatry. 2011 Feb;19(2):151-159.
    2011-02 Differential relationships of family drinking with alcohol expectancy among urban school children BMC Public Health. 2011 Feb;11:Article Number 87.
    2010-07 Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients Biomedical Chromatography. 2010 Jul;24(7):782-788.
    2010-05 Three-year mortality and predictors after release: a longitudinal study of the first-time drug offenders in Taiwan Addiction. 2010 May;105(5):920-927.
    2010-04 Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response Pharmacogenomics. 2010 Apr;11(4):537-546.
    2010-02 ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics Pharmacogenomics Journal. 2010 Feb;10(1):30-39.
    2010-01 Ethnic differences in antidepressant response: A prospective multi-site clinical trial Depression and Anxiety. 2010 Jan;27(1):56-62.
    2009-10 Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan Acta Psychiatrica Scandinavica. 2009 Oct;120(4):274-280.
    2009-10 5-HT2A gene variants and antidepressant response in Japanese and Italian mood disorder patients Pharmacogenomics. 2009 Oct;10(10):1568.
    2009-10 BDNF and its association with major depression and antidepressant treatment response Pharmacogenomics. 2009 Oct;10(10):1567-1568.
    2009-10 Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response Pharmacogenomics. 2009 Oct;10(10):1566-1567.
    2009-10 Progress in the pharmacogenomics of antidepressant response Pharmacogenomics. 2009 Oct;10(10):1565.
    2009-10 Catechol-O-methyltransferase polymorphism and acute antidepressant response to sleep deprivation with light therapy Pharmacogenomics. 2009 Oct;10(10):1565-1566.
    2009-09-01 Predictors of the incidence and discontinuation of long-term use of benzodiazepines: A population-based study Drug and Alcohol Dependence. 2009 Sep 1;104(1-2):140-146.
    2009-09 Biological variations in depression and anxiety between east and west Cns Neuroscience & Therapeutics. 2009 Sep;15(3):283-294.
    2009-07 The association between dementia and long-term use of benzodiazepine in the elderly: Nested case-control study using claims data American Journal of Geriatric Psychiatry. 2009 Jul;17(7):614-620.
    2009-05 Health consequences of illegal drug use Current Opinion in Psychiatry. 2009 May;22(3):287-292.
    2009-03 Increased Risks of Congenital, Neurologic, and Endocrine Disorders Associated with Autism in Preschool Children: Cognitive Ability Differences Journal of Pediatrics. 2009 Mar;154(3):345-350.e341.
    2008-10 Ethnopsychopharmacology International Review of Psychiatry. 2008 Oct;20(5):452-459.
    2008-08 Benzodiazepine and risk of hip fractures in older people: A nested case-control study in Taiwan American Journal of Geriatric Psychiatry. 2008 Aug;16(8):686-692.
    2008-06 Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan International Journal of Geriatric Psychiatry. 2008 Jun;23(6):618-624.
    2008-03 Urbanicity-related variation in help-seeking and services utilization among preschool-age children with autism in Taiwan Journal of Autism and Developmental Disorders. 2008 Mar;38(3):489-497.
    2008 Pharmacogenomic strategy for individualizing antidepressant therapy Dialogues in Clinical Neuroscience. 2008;10(4):401-408.
    2007-02 Factors associated with the diagnosis of neurodevelopmental disorders: A population-based longitudinal study Pediatrics. 2007 Feb;119(2):E435-E443.
    2007-01 Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan Pharmacoepidemiology and Drug Safety. 2007 Jan;16(1):86-95.
    2006-07 Genetic polymorphism of cytochrome P4502C19 in Mexican Americans: A cross-ethnic comparative study Clinical Pharmacology and Therapeutics. 2006 Jul;80(1):33-40.
    2006 Biological Psychiatry in Taiwan: History and Future Directions Brain Science and Mental Disorders. 2006;17(2):179-187.
    2004 Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups American Journal of PharmacoGenomics. 2004;4(6):395-401.

    顯示項目1-49 / 49. (共1頁)
    1 
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋